Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance
13 mai 2024 08h00 HE
|
Science 37, Inc.
Science 37 Holdings, Inc. today announced the preliminary outcome of its recent FDA Inspection focusing on critical areas and documentation.
Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”
09 mai 2024 10h00 HE
|
Science 37, Inc.
Science 37 announces its selection as the winner of the “Clinical Efficiency Innovation Award” in the 8th annual MedTech Breakthrough Awards program.
Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial
02 mai 2024 08h00 HE
|
Science 37, Inc.
Science 37's Metasite™ and Patient Recruitment Solutions together dramatically boost patient enrollment in a Phase 3 asthma clinical trial.
Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment
17 avr. 2024 08h00 HE
|
Science 37, Inc.
Science 37's Patient Recruitment Solution provides fully-consented patients to clinical trial sites to supplement enrollment.
Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment
29 janv. 2024 07h30 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (the “Company” or “Science 37”), the clinical research industry’s leading MetasiteTM, today...
Science 37 Receives Top Honors in Everest PEAK Matrix®
12 déc. 2023 08h00 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™ today announced that it has been named a...
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
07 déc. 2023 16h59 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards...
Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023
05 déc. 2023 07h00 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (“Science 37” or the “Company”), the clinical research industry-leading Metasite™, announced...
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
10 nov. 2023 16h39 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards...
Science 37 Reports Third Quarter 2023 Financial Results
07 nov. 2023 06h00 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the...